Author: Samuel J. S. Rubin; Samuel Robert Falkson; Nicholas Degner; Catherine Blish
Title: Clinical characteristics associated with COVID-19 severity in California Document date: 2020_3_30
ID: as6tbfrh_14
Snippet: The potential role of the RAAS system in COVID-19 pathogenesis stems from mounting sequence and structural evidence indicating entry of SARS-CoV-2 via interaction of its spike protein with its human host receptor angiotensin-converting enzyme 2 (ACE2) (5). It is difficult to predict the effects of RAAS blockade in treatment of COVID-19, as it may increase expression of ACE2, with known anti-inflammatory and pulmonary protective properties, yet si.....
Document: The potential role of the RAAS system in COVID-19 pathogenesis stems from mounting sequence and structural evidence indicating entry of SARS-CoV-2 via interaction of its spike protein with its human host receptor angiotensin-converting enzyme 2 (ACE2) (5). It is difficult to predict the effects of RAAS blockade in treatment of COVID-19, as it may increase expression of ACE2, with known anti-inflammatory and pulmonary protective properties, yet simultaneously promote viral entry (6). However, RAAS blockade may also increase soluble ACE2, which could serve as a decoy receptor protecting against viral entry.
Search related documents:
Co phrase search for related documents- angiotensin convert and human host receptor: 1
- angiotensin convert and SARS entry: 1
- angiotensin convert and spike protein: 1
- angiotensin convert enzyme and human host: 1
- angiotensin convert enzyme and human host receptor: 1
- decoy receptor and human host: 1, 2
- decoy receptor and human host receptor: 1, 2
- decoy receptor and SARS entry: 1, 2
- decoy receptor and spike protein: 1, 2, 3, 4, 5, 6, 7, 8
- decoy receptor and viral entry: 1, 2, 3
- human host and pathogenesis stem: 1
- human host and potential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- human host and RAAS system: 1
- human host and SARS entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- human host and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- human host and structural evidence: 1
- human host and viral entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62
- human host receptor and potential role: 1, 2, 3, 4
- human host receptor and SARS entry: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date